BostonGene

BostonGene's Chief Medical Officer is scheduled to speak at the 2nd Annual Global Cancer Research & Innovation Symposium, where the focus will be on biologically grounded artificial intelligence and the use of multimodal data in oncology drug development. The company argues that combining AI with biological context can improve how cancer therapies are discovered and developed.